SCHEMBL7472685

SCHEMBL7472685

Cc1cc(-c2cc[c]cc2)c(C)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GALR3 O60755 1/20 0.38
GAA P10253 1/20 0.38
PDE3B Q13370 3/20 0.37
PDE3A Q14432 3/20 0.37
PDE4A P27815 2/20 0.37
PDE4B Q07343 2/20 0.37
PDE4C Q08493 2/20 0.37
PDE4D Q08499 2/20 0.37
PDE5A O76074 1/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.36
PTGS1 P23219 1/20 0.36
CYP2C19 P33261 1/20 0.36
BLM P54132 1/20 0.36
AURKB Q96GD4 1/20 0.35
INCENP Q9NQS7 1/20 0.35
CCNC P24863 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504485 0.78 PDE3B (0.56) HPGDALDH1A1KDM4EGALR3GAA
SCHEMBL2320354 0.75 AHR (0.41) HPGDKDM4EGAAPDE3BPDE3A
SCHEMBL9188011 0.75 NPC1 (0.48) HPGDALDH1A1KDM4EGALR3GAA
SCHEMBL14154838 0.75 ALK (0.44) ALDH1A1KDM4EGAAPDE3BPDE3A
SCHEMBL4921058 0.75 ALDH1A1 (0.45) HPGDALDH1A1KDM4EGALR3GAA
SCHEMBL9382851 0.72 ABL1 (0.47) HPGDALDH1A1KDM4ECYP2C19
SCHEMBL10890730 0.71 GAA (0.43) GAAPDE3BPDE3APDE4APDE4B
SCHEMBL6196824 0.68 NQO1 (0.48) HPGDALDH1A1KDM4EGAALMNA
SCHEMBL5270008 0.66 ALK (0.56) ALDH1A1CYP2C19AURKBCDK8JAK2
SCHEMBL17183457 0.65 L3MBTL1 (0.66) KDM4EGAALMNACYP2C19AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0937708-B1 Sulphonamide derivatives LILLY CO ELI (US) 2002-12-18 EP claimed
US-6362230-B1 ALZHEIMER'S DISEASE ELI LILLY AND COMPANY 2002-03-26 US claimed
US-6174922-B1 FOR POTENTIATING GLUTAMATE RECEPTOR FUNCTION IN WARM BLOODED MAMMAL ELI LILLY AND COMPANY 2001-01-16 US claimed
WO-1999043285-A2 SULPHONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 1999-09-02 WO claimed
EP-0937708-A2 sulphonamide derivatives ELI LILLY AND COMPANY (US) 1999-08-25 EP claimed
EP-0937708-B1 Sulphonamide derivatives LILLY CO ELI (US) 2002-12-18 EP disclosed
US-6362230-B1 ALZHEIMER'S DISEASE ELI LILLY AND COMPANY 2002-03-26 US disclosed
US-6174922-B1 FOR POTENTIATING GLUTAMATE RECEPTOR FUNCTION IN WARM BLOODED MAMMAL ELI LILLY AND COMPANY 2001-01-16 US disclosed
EP-0937708-A2 sulphonamide derivatives ELI LILLY AND COMPANY (US) 1999-08-25 EP disclosed